Pasar al contenido principal

ESTRATEGIAS PARA SILENCIAR LA COMUNICACION ENTRE LOS FIBROBLASTOS-ASOCIADOS A CANCER Y EL MICROAMBIENTE TUMORAL EN CANCER COLORECTAL

PID2021-128107OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Stromal cells regulate mechanics of tumour spheroid

  • Agrawal, Ayushi
  • Lasli, Soufian
  • Javanmardi, Yousef
  • Coursier, Diane
  • Micalet, Auxtine
  • Watson, Sara
  • Shahreza, Somayeh
  • Serwinski, Bianca
  • Djordjevic, Boris
  • Szita, Nicolas
  • Cheema, Umber
  • Bertazzo, Sergio
  • Calvo, Fernando
  • Moeendarbary, Emad
The remarkable contractility and force generation ability exhibited by cancer cells empower them to overcome the resistance and steric hindrance presented by a three-dimensional, interconnected matrix. Cancer cells disseminate by actively remodelling and deforming their extracellular matrix (ECM). The process of tumour growth and its ECM remodelling have been extensively studied, but the effect of the cellular tumour microenvironment (TME) has been ignored in most studies that investigated tumour-cell-mediated ECM deformations and realignment. This study reports the integration of stromal cells in spheroid contractility assays that impacts the ECM remodelling and invasion abilities of cancer spheroids. To investigate this, we developed a novel multilayer in vitro assay that incorporates stromal cells and quantifies the contractile deformations that tumour spheroids exert on the ECM. We observed a negative correlation between the spheroid invasion potential and the levels of collagen deformation. The presence of stromal cells significantly increased cancer cell invasiveness and altered the cancer cells' ability to deform and realign collagen gel, due to upregulation of proinflammatory cytokines. Interestingly, this was observed consistently in both metastatic and non-metastatic cancer cells. Our findings contribute to a better understanding of the vital role played by the cellular TME in regulating the invasive outgrowth of cancer cells and underscore the potential of utilising matrix deformation measurements as a biophysical marker for evaluating invasiveness and informing targeted therapeutic opportunities., AA, EM, and FC are grateful for the financial support by the Cancer Research UK Multidisciplinary Award (C57744/A22057). EM acknowledge financial support by Welcome Trust-MIT Fellowship (WT103883), Leverhulme Trust Research Project Grant (RPG-2018-443), BBSRC (BB/V001418/1). FC was funded by MCIN/AEI/10.13039/501100011033 (RYC-2016-20352, RTI2018-096778-A-I00, PID2021-128107OB-I00); AECC (LABAE19044CALV, PRYCO211372RODR); BBVA Leonardo Awards (IN[19]_BBM_BAS_0076), and the ERC (Consolidator Grant 101045756)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Endothelium and Subendothelial Matrix Mechanics Modulate Cancer Cell Transendothelial Migration

  • Javanmardi, Yousef
  • Agrawal, Ayushi
  • Malandrino, Andrea
  • Lasli, Soufian
  • Chen, Michelle
  • Shahreza, Somayeh
  • Serwinski, Bianca
  • Cammoun, Leila
  • Li, Ran
  • Jorfi, Mehdi
  • Djordjevic, Boris
  • Szita, Nicolás
  • Spill, Fabián
  • Bertazzo, Sergio
  • Sheridan, Graham K.
  • Shenoy, Vivek
  • Calvo, Fernando
  • Kamm, Roger
  • Moeendarbary, Emad
Cancer cell extravasation, a key step in the metastatic cascade, involves cancer cell arrest on the endothelium, transendothelial migration (TEM), followed by the invasion into the subendothelial extracellular matrix (ECM) of distant tissues. While cancer research has mostly focused on the biomechanical interactions between tumor cells (TCs) and ECM, particularly at the primary tumor site, very little is known about the mechanical properties of endothelial cells and the subendothelial ECM and how they contribute to the extravasation process. Here, an integrated experimental and theoretical framework is developed to investigate the mechanical crosstalk between TCs, endothelium and subendothelial ECM during in vitro cancer cell extravasation. It is found that cancer cell actin-rich protrusions generate complex push-pull forces to initiate and drive TEM, while transmigration success also relies on the forces generated by the endothelium. Consequently, mechanical properties of the subendothelial ECM and endothelial actomyosin contractility that mediate the endothelial forces also impact the endothelium's resistance to cancer cell transmigration. These results indicate that mechanical features of distant tissues, including force interactions between the endothelium and the subendothelial ECM, are key determinants of metastatic organotropism., E.M. is grateful for Welcome Trust-MIT Fellowship (WT103883). Y.J. and E.M. acknowledge financial support by Leverhulme Trust Research Project Grant (RPG-2018-443) and the Cancer Research UK Multidisciplinary Award (C57744/A22057). Y.J., E.M., and F.S are grateful for Biotechnology and Biological Sciences Research Council Grant (BB/V001418/1) supports. R.K. and V.S. acknowledge the support from NIH (U54CA261694). F.S. was supported by a UKRI Future Leaders Fellowship, grant number [MR/T043571/1]. F.C. was funded by MCIN/AEI/ 10.13039/501100011033 (RYC-2016-20352, RTI2018-096778-A-I00, PID2021-128107OB-I00); AECC (LABAE19044CALV, PRYCO211372RODR); BBVA Leonardo Awards (IN[19]_BBM_BAS_0076), Cancer Research UK (C57744/A22057) and the ERC (Consolidator Grant 101045756)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CAFs vs. TECs: when blood feuds fuel cancer progression, dissemination and therapeutic resistance

  • Coursier, Diana
  • Calvo, Fernando
Neoplastic progression involves complex interactions between cancer cells and the surrounding stromal milieu, fostering microenvironments that crucially drive tumor progression and dissemination. Of these stromal constituents, cancer-associated fibroblasts (CAFs) emerge as predominant inhabitants within the tumor microenvironment (TME), actively shaping multiple facets of tumorigenesis, including cancer cell proliferation, invasiveness, and immune evasion. Notably, CAFs also orchestrate the production of pro-angiogenic factors, fueling neovascularization to sustain the metabolic demands of proliferating cancer cells. Moreover, CAFs may also directly or indirectly affect endothelial cell behavior and vascular architecture, which may impact in tumor progression and responses to anti-cancer interventions. Conversely, tumor endothelial cells (TECs) exhibit a corrupted state that has been shown to affect cancer cell growth and inflammation. Both CAFs and TECs are emerging as pivotal regulators of the TME, engaging in multifaceted biological processes that significantly impact cancer progression, dissemination, and therapeutic responses. Yet, the intricate interplay between these stromal components and the orchestrated functions of each cell type remains incompletely elucidated. In this review, we summarize the current understanding of the dynamic interrelationships between CAFs and TECs, discussing the challenges and prospects for leveraging their interactions towards therapeutic advancements in cancer., Spanish Government MCIN/AEI/10.13039/501100011033 (grants RYC-2016‐20352, RTI2018‐096778‐A‐I00, PID2021‐128107OB‐I00); Asociación Española Contra el Cáncer-AECC (grants LABAE19044CALV, PRYCO211372RODR); BBVA Leonardo Awards (grant IN [19]_BBM_BAS_0076), Cancer Research UK (grant C57744/A22057); and the European Research Council-ERC Consolidator Grant antiCAFing (grant ref 101045756). Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Lockpicking FGFR1 with aptamer-based technology

  • Nonatelli, Francesca
  • Pastor, Fernando
  • Calvo, Fernando
Targeting undruggable proteins and achieving high selectivity remain critical challenges in molecular therapeutics, as the lack of well-defined binding pockets, along with off-target effects leading to toxicity and reduced efficacy, often hampers drug development. The study by Zlinska et al.1 leverages aptamer technology to develop new molecular and therapeutic tools for fibroblast growth factor receptor-1 (FGFR1) modulation. It describes a novel DNA G-quadruplex aptamer (called VZ23), which specifically binds to FGFR1 without affecting other FGFR variants, effectively inhibiting FGFR1 signaling and its cellular responses (Figure 1). This finding offers new potential solutions for treating several pathologies where FGFR1 is relevant, including cancer, skeletal and developmental disorders, and metabolic syndromes., This work was supported by grants to F.C. from the Spanish Government MICIU/AEI/10.13039/501100011033 (PID2021-128107OB-I00); Asociación Española Contra el Cáncer-AECC (PRYCO211372RODR), and the European Research Council-ERC Consolidator Grant antiCAFing (grant no. 101045756). F.P. is supported by Instituto de Salud Carlos III y Fondos Feder (PI23/01120), Estratégicos Asociación Española Contra el Cáncer (AECC PRYES235096PAST), H2020-FETOPEN “DESTINATION” (grant no. 899833), and Gobierno de Navarra Estratégicos “REVOLUTION” (0011-1411-2024-000110)., Peer reviewed